| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Malaria | 13 | 2019 | 1097 | 2.27 | Why? |
| Mozambique | 27 | 2019 | 205 | 2.22 | Why? |
| Malaria, Falciparum | 11 | 2019 | 377 | 2.10 | Why? |
| Plasmodium falciparum | 10 | 2019 | 337 | 2.00 | Why? |
| Child Mortality | 7 | 2019 | 163 | 1.96 | Why? |
| Antimalarials | 15 | 2019 | 2505 | 1.58 | Why? |
| Infant Mortality | 5 | 2019 | 268 | 1.57 | Why? |
| Autopsy | 13 | 2019 | 3495 | 1.39 | Why? |
| Cause of Death | 14 | 2019 | 4823 | 1.14 | Why? |
| Malaria, Vivax | 7 | 2019 | 152 | 1.14 | Why? |
| Peer Review, Research | 2 | 2019 | 407 | 1.13 | Why? |
| Editorial Policies | 2 | 2019 | 408 | 1.05 | Why? |
| Plasmodium vivax | 6 | 2019 | 154 | 1.02 | Why? |
| Streptococcus agalactiae | 3 | 2018 | 194 | 1.00 | Why? |
| Yaws | 3 | 2018 | 5 | 0.96 | Why? |
| Periodicals as Topic | 3 | 2019 | 1492 | 0.90 | Why? |
| Artemisinins | 4 | 2019 | 238 | 0.85 | Why? |
| Cryogels | 1 | 2019 | 4 | 0.82 | Why? |
| Echoencephalography | 1 | 2019 | 6 | 0.81 | Why? |
| Polyvinyl Alcohol | 1 | 2019 | 9 | 0.81 | Why? |
| Cholera | 2 | 2021 | 189 | 0.80 | Why? |
| Quinolines | 3 | 2018 | 403 | 0.79 | Why? |
| Anemia, Myelophthisic | 1 | 2018 | 8 | 0.78 | Why? |
| Phantoms, Imaging | 1 | 2019 | 146 | 0.75 | Why? |
| Severe Acute Malnutrition | 1 | 2018 | 19 | 0.75 | Why? |
| Enterobacter cloacae | 1 | 2018 | 58 | 0.75 | Why? |
| Erythema Infectiosum | 1 | 2018 | 31 | 0.74 | Why? |
| Publishing | 2 | 2018 | 990 | 0.72 | Why? |
| Malaria, Cerebral | 1 | 2018 | 37 | 0.71 | Why? |
| Diarrhea | 3 | 2019 | 2743 | 0.69 | Why? |
| Linear IgA Bullous Dermatosis | 1 | 2017 | 11 | 0.69 | Why? |
| Stillbirth | 4 | 2019 | 544 | 0.68 | Why? |
| Enterovirus Infections | 2 | 2021 | 404 | 0.66 | Why? |
| Dapsone | 1 | 2017 | 59 | 0.65 | Why? |
| Scientific Misconduct | 1 | 2018 | 101 | 0.65 | Why? |
| Travel Medicine | 1 | 2019 | 335 | 0.60 | Why? |
| Cyclonic Storms | 1 | 2019 | 236 | 0.59 | Why? |
| Capacity Building | 1 | 2020 | 683 | 0.54 | Why? |
| Checklist | 1 | 2019 | 714 | 0.52 | Why? |
| Infant, Newborn | 24 | 2019 | 23105 | 0.51 | Why? |
| Hypoglycemia | 1 | 2018 | 406 | 0.50 | Why? |
| Infant | 29 | 2021 | 30274 | 0.50 | Why? |
| Data Accuracy | 1 | 2018 | 715 | 0.49 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.49 | Why? |
| Printing, Three-Dimensional | 1 | 2019 | 624 | 0.49 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.49 | Why? |
| Surge Capacity | 1 | 2020 | 894 | 0.48 | Why? |
| Child, Preschool | 30 | 2021 | 36283 | 0.45 | Why? |
| Cytomegalovirus Infections | 1 | 2018 | 667 | 0.44 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.43 | Why? |
| Climate Change | 1 | 2019 | 901 | 0.42 | Why? |
| Streptococcal Infections | 3 | 2018 | 255 | 0.42 | Why? |
| Health Resources | 3 | 2020 | 2592 | 0.41 | Why? |
| Child | 32 | 2022 | 70012 | 0.39 | Why? |
| Global Health | 7 | 2020 | 13911 | 0.39 | Why? |
| Primaquine | 2 | 2019 | 62 | 0.38 | Why? |
| Treponema pallidum | 3 | 2018 | 42 | 0.38 | Why? |
| Plasmodium | 2 | 2019 | 74 | 0.37 | Why? |
| Malnutrition | 1 | 2018 | 932 | 0.36 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.35 | Why? |
| Anopheles | 2 | 2018 | 89 | 0.35 | Why? |
| Cryptosporidiosis | 2 | 2019 | 46 | 0.35 | Why? |
| Pediatrics | 2 | 2020 | 2969 | 0.34 | Why? |
| Immunity | 1 | 2019 | 2651 | 0.33 | Why? |
| Azithromycin | 4 | 2020 | 3943 | 0.33 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.32 | Why? |
| Papua New Guinea | 4 | 2018 | 63 | 0.32 | Why? |
| Glucosephosphate Dehydrogenase Deficiency | 2 | 2019 | 198 | 0.29 | Why? |
| Escherichia coli Infections | 2 | 2019 | 348 | 0.29 | Why? |
| Anti-Infective Agents | 1 | 2017 | 1766 | 0.29 | Why? |
| Disease Eradication | 4 | 2019 | 581 | 0.28 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.28 | Why? |
| Humans | 91 | 2022 | 930598 | 0.27 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2018 | 5164 | 0.26 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.26 | Why? |
| Pneumonia | 2 | 2020 | 5652 | 0.26 | Why? |
| Africa South of the Sahara | 5 | 2019 | 1335 | 0.25 | Why? |
| Specimen Handling | 5 | 2021 | 6190 | 0.24 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.24 | Why? |
| Political Systems | 1 | 2021 | 38 | 0.22 | Why? |
| Drug Resistance | 3 | 2018 | 395 | 0.22 | Why? |
| Pneumococcal Infections | 2 | 2018 | 562 | 0.22 | Why? |
| Female | 53 | 2021 | 380317 | 0.21 | Why? |
| Antibodies, Protozoan | 2 | 2018 | 121 | 0.21 | Why? |
| Antigens, Protozoan | 2 | 2018 | 121 | 0.21 | Why? |
| Mass Drug Administration | 2 | 2018 | 143 | 0.21 | Why? |
| Anti-Bacterial Agents | 4 | 2020 | 10083 | 0.20 | Why? |
| Adolescent | 25 | 2021 | 86841 | 0.20 | Why? |
| Hemolysis | 2 | 2019 | 283 | 0.20 | Why? |
| Maternal Mortality | 3 | 2019 | 461 | 0.20 | Why? |
| Delivery of Health Care | 3 | 2020 | 15909 | 0.20 | Why? |
| Adrenal Cortex Hormones | 1 | 2017 | 6537 | 0.20 | Why? |
| Vibrio cholerae | 1 | 2019 | 44 | 0.19 | Why? |
| Pregnancy Complications, Parasitic | 1 | 2018 | 23 | 0.19 | Why? |
| Male | 45 | 2021 | 367725 | 0.19 | Why? |
| Tuberculosis, Miliary | 1 | 2019 | 66 | 0.19 | Why? |
| Biomimetic Materials | 1 | 2019 | 70 | 0.18 | Why? |
| Mosquito Vectors | 2 | 2018 | 351 | 0.18 | Why? |
| HIV Infections | 4 | 2019 | 11620 | 0.18 | Why? |
| Postmortem Changes | 1 | 2018 | 133 | 0.18 | Why? |
| Anemia, Hemolytic | 1 | 2019 | 70 | 0.18 | Why? |
| Haemophilus ducreyi | 1 | 2017 | 2 | 0.18 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.17 | Why? |
| Decision Trees | 1 | 2019 | 441 | 0.17 | Why? |
| Ciprofloxacin | 1 | 2018 | 130 | 0.17 | Why? |
| Meningitis | 1 | 2019 | 163 | 0.17 | Why? |
| Hospitals, District | 1 | 2018 | 136 | 0.17 | Why? |
| Diptera | 1 | 2017 | 30 | 0.17 | Why? |
| Thiazolidinediones | 1 | 2017 | 70 | 0.17 | Why? |
| Puerperal Infection | 1 | 2017 | 26 | 0.17 | Why? |
| Prevalence | 11 | 2019 | 25773 | 0.16 | Why? |
| Online Systems | 1 | 2019 | 240 | 0.16 | Why? |
| Rural Population | 3 | 2018 | 2408 | 0.16 | Why? |
| Metapneumovirus | 1 | 2019 | 465 | 0.16 | Why? |
| Glucosephosphate Dehydrogenase | 1 | 2017 | 85 | 0.16 | Why? |
| Maternal Death | 1 | 2017 | 108 | 0.16 | Why? |
| Infant, Small for Gestational Age | 1 | 2017 | 151 | 0.16 | Why? |
| Community-Based Participatory Research | 1 | 2018 | 271 | 0.16 | Why? |
| Paramyxoviridae Infections | 1 | 2019 | 364 | 0.15 | Why? |
| Population Surveillance | 5 | 2021 | 4967 | 0.15 | Why? |
| Picornaviridae Infections | 1 | 2021 | 544 | 0.15 | Why? |
| Vagina | 1 | 2018 | 327 | 0.15 | Why? |
| Asymptomatic Infections | 4 | 2021 | 7218 | 0.15 | Why? |
| Mental Disorders | 1 | 2019 | 6742 | 0.15 | Why? |
| Streptococcus pneumoniae | 2 | 2018 | 827 | 0.15 | Why? |
| Erythrocytes | 2 | 2019 | 617 | 0.14 | Why? |
| Rectum | 1 | 2018 | 495 | 0.14 | Why? |
| Crowdsourcing | 1 | 2019 | 258 | 0.14 | Why? |
| Rotavirus Infections | 1 | 2019 | 355 | 0.14 | Why? |
| Pilot Projects | 4 | 2019 | 5182 | 0.14 | Why? |
| Video Games | 1 | 2019 | 270 | 0.14 | Why? |
| Liberia | 3 | 2018 | 108 | 0.14 | Why? |
| Mental Health | 1 | 2021 | 15770 | 0.14 | Why? |
| Polymers | 1 | 2019 | 507 | 0.14 | Why? |
| Parasitemia | 3 | 2018 | 88 | 0.13 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2019 | 433 | 0.13 | Why? |
| Family Characteristics | 3 | 2019 | 2551 | 0.13 | Why? |
| Pregnancy | 11 | 2019 | 23879 | 0.13 | Why? |
| Chloroquine | 2 | 2020 | 3152 | 0.13 | Why? |
| Young Adult | 19 | 2021 | 93724 | 0.13 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2018 | 398 | 0.13 | Why? |
| Neglected Diseases | 1 | 2018 | 381 | 0.13 | Why? |
| Death | 1 | 2016 | 334 | 0.13 | Why? |
| Respiratory Syncytial Viruses | 1 | 2017 | 612 | 0.13 | Why? |
| Brazil | 9 | 2021 | 12582 | 0.12 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.12 | Why? |
| Adult | 31 | 2022 | 244371 | 0.12 | Why? |
| Polymerase Chain Reaction | 5 | 2019 | 6740 | 0.12 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2019 | 846 | 0.12 | Why? |
| Renal Insufficiency | 1 | 2019 | 810 | 0.12 | Why? |
| Qualitative Research | 3 | 2019 | 4337 | 0.12 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.11 | Why? |
| Prenatal Care | 2 | 2019 | 1314 | 0.11 | Why? |
| Double-Blind Method | 5 | 2021 | 5988 | 0.11 | Why? |
| Schools | 3 | 2022 | 4187 | 0.11 | Why? |
| Fomites | 1 | 2017 | 709 | 0.11 | Why? |
| Congresses as Topic | 1 | 2020 | 1347 | 0.10 | Why? |
| Child Health | 1 | 2019 | 940 | 0.10 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2019 | 1234 | 0.10 | Why? |
| Leukocytes, Mononuclear | 1 | 2019 | 2115 | 0.10 | Why? |
| South Africa | 4 | 2019 | 3326 | 0.10 | Why? |
| Tuberculosis, Pulmonary | 1 | 2019 | 1171 | 0.09 | Why? |
| Cost of Illness | 2 | 2018 | 1903 | 0.09 | Why? |
| Respiratory Tract Diseases | 1 | 2017 | 1061 | 0.09 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.09 | Why? |
| Real-Time Polymerase Chain Reaction | 5 | 2021 | 11367 | 0.09 | Why? |
| Long QT Syndrome | 1 | 2018 | 1047 | 0.09 | Why? |
| Immunomodulation | 1 | 2018 | 1472 | 0.09 | Why? |
| DNA, Protozoan | 2 | 2018 | 77 | 0.09 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.09 | Why? |
| Prospective Studies | 8 | 2021 | 43301 | 0.09 | Why? |
| Vaccination Coverage | 1 | 2018 | 1249 | 0.09 | Why? |
| Mali | 2 | 2019 | 181 | 0.09 | Why? |
| Cross-Sectional Studies | 10 | 2021 | 53120 | 0.09 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.09 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.09 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.09 | Why? |
| BCG Vaccine | 1 | 2018 | 1137 | 0.08 | Why? |
| Influenza A virus | 1 | 2019 | 2234 | 0.08 | Why? |
| Perception | 1 | 2018 | 2827 | 0.08 | Why? |
| Perinatal Death | 2 | 2019 | 372 | 0.08 | Why? |
| Asia | 3 | 2019 | 2399 | 0.08 | Why? |
| Respiratory Tract Infections | 2 | 2017 | 6817 | 0.08 | Why? |
| Pregnancy Complications | 1 | 2017 | 1388 | 0.08 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.08 | Why? |
| Emergencies | 1 | 2021 | 4095 | 0.08 | Why? |
| Maternal Age | 2 | 2017 | 244 | 0.08 | Why? |
| Pregnancy Complications, Infectious | 4 | 2019 | 11559 | 0.07 | Why? |
| Spain | 5 | 2022 | 15545 | 0.07 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.07 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.07 | Why? |
| Case-Control Studies | 3 | 2019 | 17671 | 0.07 | Why? |
| Delivery of Health Care, Integrated | 1 | 2017 | 1549 | 0.07 | Why? |
| Kenya | 2 | 2019 | 887 | 0.07 | Why? |
| Risk Factors | 6 | 2019 | 71621 | 0.07 | Why? |
| Skin | 1 | 2017 | 2096 | 0.07 | Why? |
| Respiratory System | 1 | 2017 | 3213 | 0.07 | Why? |
| Pregnant Women | 1 | 2018 | 2535 | 0.07 | Why? |
| Survival Rate | 1 | 2019 | 9206 | 0.07 | Why? |
| Communicable Diseases | 1 | 2019 | 2148 | 0.07 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.07 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.07 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.07 | Why? |
| Models, Statistical | 2 | 2021 | 5312 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.06 | Why? |
| Fever | 2 | 2018 | 7795 | 0.06 | Why? |
| Students | 1 | 2021 | 5255 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Feces | 1 | 2016 | 4235 | 0.06 | Why? |
| Bangladesh | 2 | 2019 | 1620 | 0.06 | Why? |
| Incidence | 6 | 2021 | 25622 | 0.06 | Why? |
| Developing Countries | 4 | 2020 | 4283 | 0.06 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.06 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.06 | Why? |
| Anemia | 2 | 2019 | 789 | 0.06 | Why? |
| Yemen | 1 | 2021 | 136 | 0.05 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Gastrointestinal Diseases | 1 | 2016 | 2580 | 0.05 | Why? |
| Schizonts | 1 | 2019 | 21 | 0.05 | Why? |
| Sulfadoxine | 1 | 2019 | 14 | 0.05 | Why? |
| Pyrimethamine | 1 | 2019 | 18 | 0.05 | Why? |
| Pandemics | 6 | 2022 | 389249 | 0.05 | Why? |
| Cell Extracts | 1 | 2019 | 27 | 0.05 | Why? |
| Trophozoites | 1 | 2019 | 13 | 0.05 | Why? |
| Africa | 2 | 2020 | 2986 | 0.05 | Why? |
| Coombs Test | 1 | 2019 | 66 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Morocco | 1 | 2021 | 449 | 0.05 | Why? |
| Cambodia | 1 | 2019 | 190 | 0.05 | Why? |
| Capital Financing | 1 | 2019 | 35 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2019 | 29620 | 0.05 | Why? |
| Dose-Response Relationship, Drug | 2 | 2020 | 3776 | 0.05 | Why? |
| Tissue Banks | 1 | 2019 | 66 | 0.05 | Why? |
| Diagnosis | 1 | 2019 | 71 | 0.05 | Why? |
| Diagnostic Tests, Routine | 2 | 2021 | 2643 | 0.05 | Why? |
| Grounded Theory | 1 | 2018 | 48 | 0.05 | Why? |
| Oocysts | 1 | 2018 | 12 | 0.05 | Why? |
| Sierra Leone | 1 | 2019 | 267 | 0.05 | Why? |
| RNA, Ribosomal, 23S | 1 | 2018 | 25 | 0.05 | Why? |
| Penicillin Resistance | 1 | 2018 | 15 | 0.05 | Why? |
| Penicillin-Binding Proteins | 1 | 2018 | 31 | 0.05 | Why? |
| Urban Renewal | 1 | 2018 | 25 | 0.05 | Why? |
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 8811 | 0.05 | Why? |
| Streptococcal Vaccines | 1 | 2018 | 31 | 0.04 | Why? |
| Stereotyping | 1 | 2021 | 249 | 0.04 | Why? |
| Chancroid | 1 | 2017 | 7 | 0.04 | Why? |
| Serotyping | 1 | 2018 | 154 | 0.04 | Why? |
| Mice | 1 | 2018 | 21357 | 0.04 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.04 | Why? |
| Life Cycle Stages | 1 | 2018 | 162 | 0.04 | Why? |
| Silver | 1 | 2021 | 327 | 0.04 | Why? |
| Stress, Psychological | 1 | 2021 | 10231 | 0.04 | Why? |
| Blood | 1 | 2018 | 274 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 13720 | 0.04 | Why? |
| Enterovirus | 1 | 2021 | 402 | 0.04 | Why? |
| Gabon | 1 | 2016 | 81 | 0.04 | Why? |
| Bacterial Load | 1 | 2017 | 179 | 0.04 | Why? |
| Honduras | 1 | 2017 | 117 | 0.04 | Why? |
| Respiratory Rate | 1 | 2021 | 691 | 0.04 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.04 | Why? |
| Malaria Vaccines | 1 | 2018 | 90 | 0.04 | Why? |
| Mosquito Control | 1 | 2019 | 237 | 0.04 | Why? |
| Proof of Concept Study | 1 | 2019 | 696 | 0.04 | Why? |
| Leg Ulcer | 1 | 2017 | 32 | 0.04 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.04 | Why? |
| Epidemiologic Studies | 1 | 2019 | 554 | 0.04 | Why? |
| Tertiary Care Centers | 3 | 2020 | 8248 | 0.04 | Why? |
| Benchmarking | 1 | 2021 | 627 | 0.04 | Why? |
| Bacteria | 2 | 2018 | 1897 | 0.04 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2017 | 159 | 0.04 | Why? |
| Obstetric Labor Complications | 1 | 2017 | 119 | 0.04 | Why? |
| Retrospective Studies | 5 | 2019 | 105322 | 0.04 | Why? |
| Cryptosporidium | 1 | 2016 | 46 | 0.04 | Why? |
| Animals | 4 | 2018 | 78931 | 0.04 | Why? |
| Immunity, Maternally-Acquired | 1 | 2018 | 179 | 0.04 | Why? |
| Oseltamivir | 1 | 2020 | 583 | 0.04 | Why? |
| Family Health | 1 | 2021 | 731 | 0.04 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2019 | 9044 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2019 | 88759 | 0.04 | Why? |
| Afghanistan | 1 | 2016 | 224 | 0.04 | Why? |
| Reference Standards | 1 | 2019 | 1163 | 0.04 | Why? |
| Rhinovirus | 1 | 2021 | 979 | 0.04 | Why? |
| Rural Health | 1 | 2018 | 243 | 0.04 | Why? |
| Ethiopia | 1 | 2019 | 1222 | 0.04 | Why? |
| Administration, Intravenous | 1 | 2019 | 1115 | 0.04 | Why? |
| Point Mutation | 1 | 2018 | 481 | 0.04 | Why? |
| Chemoprevention | 1 | 2019 | 585 | 0.03 | Why? |
| Species Specificity | 1 | 2019 | 1356 | 0.03 | Why? |
| Culture | 1 | 2018 | 370 | 0.03 | Why? |
| Microscopy | 1 | 2018 | 414 | 0.03 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.03 | Why? |
| Comorbidity | 1 | 2019 | 34796 | 0.03 | Why? |
| Genome, Bacterial | 1 | 2018 | 446 | 0.03 | Why? |
| Philippines | 1 | 2017 | 568 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2018 | 10697 | 0.03 | Why? |
| Gestational Age | 1 | 2019 | 1488 | 0.03 | Why? |
| Endemic Diseases | 1 | 2018 | 480 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2018 | 21571 | 0.03 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.03 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.03 | Why? |
| Spatial Analysis | 1 | 2019 | 878 | 0.03 | Why? |
| Pre-Eclampsia | 1 | 2019 | 599 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.03 | Why? |
| Indonesia | 1 | 2017 | 1022 | 0.03 | Why? |
| Peru | 1 | 2017 | 1010 | 0.03 | Why? |
| Colombia | 1 | 2017 | 1241 | 0.03 | Why? |
| Terminology as Topic | 1 | 2017 | 546 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Infant, Premature | 1 | 2017 | 883 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Aged | 5 | 2020 | 215776 | 0.03 | Why? |
| Health Personnel | 2 | 2019 | 29646 | 0.03 | Why? |
| Rural Health Services | 1 | 2018 | 496 | 0.03 | Why? |
| Cluster Analysis | 1 | 2019 | 3001 | 0.03 | Why? |
| Geography | 1 | 2017 | 1801 | 0.03 | Why? |
| Virulence | 1 | 2018 | 2172 | 0.03 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.03 | Why? |
| Gastrointestinal Tract | 1 | 2018 | 1113 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Mycobacterium tuberculosis | 1 | 2019 | 1164 | 0.03 | Why? |
| Methylprednisolone | 1 | 2021 | 2107 | 0.03 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Data Mining | 1 | 2016 | 767 | 0.02 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.02 | Why? |
| Placenta | 1 | 2019 | 1531 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2018 | 1672 | 0.02 | Why? |
| Pakistan | 1 | 2016 | 2302 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Continuity of Patient Care | 1 | 2018 | 1574 | 0.02 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2018 | 1475 | 0.02 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.02 | Why? |
| Cities | 1 | 2018 | 4937 | 0.02 | Why? |
| Transcriptome | 1 | 2019 | 3466 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2018 | 2585 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.02 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Premature Birth | 1 | 2017 | 2151 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2017 | 3444 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Electrocardiography | 1 | 2018 | 3957 | 0.02 | Why? |
| Thrombocytopenia | 1 | 2017 | 2093 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Patient Safety | 1 | 2018 | 4885 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.02 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.01 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.01 | Why? |
| Immunoassay | 1 | 2016 | 4485 | 0.01 | Why? |
| Immunoglobulin M | 1 | 2018 | 9091 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
| Health Policy | 1 | 2019 | 6242 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| India | 1 | 2016 | 11875 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Lung | 1 | 2017 | 31049 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |